Form 4: uniQure CEO Matthew Kapusta Receives Stock Options and Restricted Share Units

CEO Matthew Kapusta of uniQure N.V. was granted stock options and restricted share units, increasing his beneficial ownership in the company.

Summary

• On March 1, 2024, Matthew C Kapusta, CEO and Managing Director of uniQure N.V., received 150,000 restricted share units and options to purchase 259,500 ordinary shares.
• The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the grant date, contingent upon continued service with the Issuer.
• The stock options vest 25% on the first anniversary of the grant date, and 6.25% quarterly thereafter until fully vested, also subject to continued service.
• Following these transactions, Kapusta beneficially owns 590,839 ordinary shares and options to purchase 259,500 ordinary shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options and restricted share units is a standard practice and indicates confidence in the CEO's leadership and the company's future.

Positives

• The grant of restricted share units and stock options aligns the CEO's interests with those of the shareholders.
• The vesting schedules incentivize continued service and commitment from the CEO.

Future Outlook

The vesting schedules for the restricted share units and stock options suggest an expectation of continued leadership and contribution from the CEO.

Industry Context

Grants of stock options and restricted share units are common practices in the biotechnology industry to incentivize and retain key executives.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotech industry, often benchmarked against peer companies of similar size and stage of development.
• Vesting schedules, like the one described, are typical to ensure long-term commitment.
• Comparable companies such as BioMarin, Sarepta Therapeutics, and Bluebird Bio also utilize stock options and restricted stock units as part of their executive compensation plans.

Stakeholder Impact

• The grant of equity to the CEO aligns his interests with those of shareholders, potentially leading to increased shareholder value.
• The vesting schedules incentivize the CEO to remain with the company, providing stability for employees and other stakeholders.

Key Dates